Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Transfusion. 2017 Jul 3;57(10):2542–2544. doi: 10.1111/trf.14218

Serologic and molecular characterization of weak D type 29

Mouna Ouchari 1, Kshitij Srivastava 1, Andrea Döscher 2, Roland Conradi 3, Saloua Jemni Yacoub 4, Franz Friedrich Wagner 2, Willy Albert Flegel 1
PMCID: PMC5612849  NIHMSID: NIHMS879797  PMID: 28671325

Background

While investigating D zygosity, Perco et al.1 found in 2003 a variant of the downstream Rhesus box with a novel RHD allele in a blood donor from a Caucasoid population. This D+C-c+E-e+ sample showed a serologic weak D phenotype. Because the serology and RHD structure were compatible with the definition of a molecular weak D type,2 the allele was assigned weak D type 29. The 2918 nucleotides of the Rhesus box (GenBank AF469473) represented the sequence of a downstream connected to a upstream Rhesus box. A second example of weak D type 29 was observed in Tunisia among 448 samples that were D negative by the indirect antiglobulin test.3 A nucleotide sequence FR745438.1 closely resembling weak D type 29 with 1 additional missense mutation and lacking 1 silent mutation was reported in 2010. None of these reports documented a detailed serologic description or the RH haplotype involved.

The nucleotide variations of weak D type 29 were dispersed throughout the RHD gene and could neither be explained easily by a few mutation events nor fitted into one of the Eurasian D and African weak D type 4 clusters. We collected fresh samples from the Tunisian donor3 and the family of the original donor FR745438 to resolve both RHD and RHCE alleles and describe the serology. A new RH haplotype was documented.

Study subjects and Methods

The DNA was extracted from EDTA-anticoagulated whole blood samples, collected with consent from 4 individuals at the blood centers in Sousse and Mainz. All methods have been described presiously (Supplemantial Methods).

Results and Discussion

Using our RH sequencing strategy (Fig. S1), we determined the RH haplotype in the Tunisian donor1 with the weak D type 29 and found 8 SNPs in the RHD coding sequence (CDS), as previously described (Fig. 1);1,3 the serologically implicated ccDee phenotype3 was confirmed at the molecular level because the RHCE gene in cis was actually the common RHCE*ce allele. The other RH haplotype (KY617093, not shown) represented an RHCE*ce variant allele associated with the RHD deletion (RHD*01N.01).

Fig. 1. RH haplotype of weak D type 29.

Fig. 1

Both RH genes are represented by boxes for the 10 exons each (RHD gene in yellow, RHCE green). Among the 8 single nucleotide polymorphisms (SNPs, black lines) in the RHD exons, 5 represented non-synonymous and 3 synonymous changes; there is no SNP in the RHCE exons. In the introns and 5′-UTRs, 19 SNPs are marked (blue lines). All depicted SNPs indicate differences relative to the reference sequences for this RHD*weak D type 29RHCE*ce haplotype (GenBank accession no. KY617089, for a total of 11,325 nucleotides, because of a 4 nucleotide deletion in RHD intron 2). The 1 variation in the promoter (−368A>G) and 2 variations in intron 3 (IVS3+117T>C and IVS3+124G>A) are SNPs of high prevalence commonly observed in many different RHD alleles and cannot be diagnostic for the RHD*weak D type 29 allele. The RHD*weak D type 29 is defined by the 8 nucleotide substitutions 178A>C, 201G>A, 203G>A, 594A>T, 667T>G, 744C>T, 957 G>A, 1025T>C in the exons (black lines).

Family trio

The RH haplotype for the original donor FR745438 and his parents were determined (Fig. S2). The father and the son shared the RHD*weak D type 29RHCE*ce haplotype that we had observed in the Tunisian donor;3 a corrected sequence has been deposited (FR745438.2). The RHD*weak D type 29 cDNA was confirmed in the father and the Tunisian donor.

Population

The Tunisian donor3 lived in the Gouvernorat Sousse. While exploring the family of the Caucasian donor in Mainz, Germany, the father unexpectedly reported to be born in the Gouvernorat Jendouba, Tunisia. The original weak D type 29 was described in a Caucasoid blood donor in Northern Germany,1 of whom the ethnic origin could not be found out.

D antigen density

Both donors with the serologic weak D type 29 phenotype were tested by flow cytometry and expressed D antigen densities of 174 and 80 D antigens per red blood cell, respectively (Table S1); this is lower than the common weak D type 2 and 5 phenotypes. The additional 3 amino acid substitutions thus have a substantial suppressive effect on the membrane integration of the variant RhD protein, because weak D type 4.2 harboring the other 2 substitutions can easily express more than 1,000 D antigen per red blood cell. The observed agglutination patterns (Table S2) correlated well with the antigen densities.4 Very weak expression of the D antigen can interfere with the interpretation of the D epitope pattern (Table S1) and should not be misunderstood as partial D.

We also compared the published Rhesus boxes, analyzed the phylogeny and modeled the RhD protein (Fig. S3–S5, Supplemental Material).

Conclusion

Our study resolved 2 seemingly closely related RHD alleles with a complex phylogenic origin, which was a conundrum since 2010. We established unambiguous data for 5 RH haplotypes spanning a DNA stretch of more than 150,000 nucleotides each on the short arm of chromosome 1. Such data can be applied to develop, evaluate and validate next generation sequencing approaches using targeted5 and long range techniques.6

Supplementary Material

Supp info

Summary statement.

We describe the serology of weak D type 29 and its RH haplotype including stretches of the introns for more than 11,329 nucleotides. The associated downstream Rhesus box and genetic events leading to this RH haplotype are discussed. Among the 147 weak D types known so far, the weak D type 29 haplotype has one of the most complex phylogenetic derivation.

Acknowledgments

The authors thank Harvey Gordon Klein for critical review of the manuscript. This work was supported by the Intramural Research Program (project ID Z99 CL999999) of the NIH Clinical Center, the Centre Regional de Transfusion Sanguine Sousse (CRTS grant UR12SP26) and a Fulbright Visiting Scholar Program to M.O (grant no. 68150490, 2015 – 2016).

Footnotes

Conflict of interest disclosure: WAF and FFW are inventors of patents for RHD genotyping owned by German Red Cross Blood Service Baden-Württemberg – Hessen. The remaining authors declared having no competing financial interest relevant to this article.

Statement of Disclaimer: The views expressed do not necessarily represent the view of the National Institutes of Health, the Department of Health and Human Services, or the U.S. Federal Government.

Authorship contribution: AD and SJY collected the samples and coordinated the blood donor study; RC identified and collected samples of the trio; AD performed the serologic testing; and MO, KS and WAF analysed the serologic data. MO, AD and KS performed the molecular testing, and MO, KS and WAF analyzed the molecular data. FFW and WAF contributed tools, methods and essential reagents. MO wrote drafts of the manuscript and WAF the final version.

References

  • 1.Perco P, Shao CP, Mayr WR, Panzer S, Legler TJ. Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type. Transfusion. 2003;43:335–9. doi: 10.1046/j.1537-2995.2003.00313.x. [DOI] [PubMed] [Google Scholar]
  • 2.Flegel WA, Denomme GA. Allo- and autoanti-D in weak D types and in partial D. Transfusion. 2012;52:2068–9. doi: 10.1111/j.1537-2995.2012.03693.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moussa H, Tsochandaridis M, Chakroun T, Jridi S, Abdelneji B, Hmida S, Silvy M, Bailly P, Gabert J, Levy-Mozziconacci A, Jemni-Yacoub S. Molecular background of D-negative phenotype in the Tunisian population. Transfus Med. 2012;22:192–8. doi: 10.1111/j.1365-3148.2012.01142.x. [DOI] [PubMed] [Google Scholar]
  • 4.Wagner FF, Frohmajer A, Ladewig B, Eicher NI, Lonicer CB, Müller TH, Siegel MH, Flegel WA. Weak D alleles express distinct phenotypes. Blood. 2000;95:2699–708. [PubMed] [Google Scholar]
  • 5.Stabentheiner S, Danzer M, Niklas N, Atzmuller S, Proll J, Hackl C, Polin H, Hofer K, Gabriel C. Overcoming methodical limits of standard RHD genotyping by next-generation sequencing. Vox Sang. 2011;100:381–8. doi: 10.1111/j.1423-0410.2010.01444.x. [DOI] [PubMed] [Google Scholar]
  • 6.Westbrook CJ, Karl JA, Wiseman RW, Mate S, Koroleva G, Garcia K, Sanchez-Lockhart M, O’Connor DH, Palacios G. No assembly required: Full-length MHC class I allele discovery by PacBio circular consensus sequencing. Hum Immunol. 2015;76:891–6. doi: 10.1016/j.humimm.2015.03.022. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp info

RESOURCES